Atlas Trials

Mechanisms of Refractory Hypertension (Reserpine)

Clinical trial NCT03223272 · COMPLETED

Trial details

NCT number
NCT03223272
Sponsor
University of Alabama at Birmingham
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Refractory Hypertension
Start date
2015-07-23
Primary completion
2020-01-31
Enrollment
7

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.